Veytics Intelligence
2026-10-09 · NASDAQ

Innovent's SYCUME Delivers Phase 3 Win In Inactive Thyroid Eye Disease

(RTTNews) - Innovent's SYCUME Delivers Phase 3 Win in Inactive Thyroid Eye Disease

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论,并结合市场和 OSINT 背景分析。